E
The startup develops gene therapy tools specifically designed to provide targeted treatments for epilepsy through precise genetic modifications. By addressing the underlying genetic causes of epilepsy, the company aims to improve patient outcomes and reduce the frequency of seizures.
Updated 2 months ago
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
UTFunding rounds are not available yet.
Founders
Product
Features
- The startup develops gene therapy tools specifically designed to provide targeted treatments for epilepsy through precise genetic modifications. By addressing the underlying genetic causes of epilepsy, the company aims to improve patient outcomes and reduce the frequency of seizures.